United States Hepatitis B and C Diagnostics Market was valued at USD 1.0 Billion in 2022 and is projected to reach USD 1.8 Billion by 2030, growing at a CAGR of 8.3% from 2024 to 2030.
The United States is witnessing a significant evolution in the diagnostics market for Hepatitis B (HBV) and Hepatitis C (HCV), driven by technological advancements and an increasing emphasis on early detection. Recent projections indicate that from 2023 to 2027, the market is poised to grow by approximately USD 2.05 billion, reflecting a compound annual growth rate (CAGR) of 6.12%. citeturn0search1
Several factors contribute to this growth:
Advancements in Molecular Diagnostics: The demand for molecular diagnostics, particularly nucleic acid tests, has surged due to their precision in detecting HBV and HCV infections. These tests have become integral in chronic infection diagnoses, offering rapid and accurate results. citeturn0search2
Emergence of Immunosensors: Innovations such as immunosensors have revolutionized HBV and HCV detection. By converting specific antibody-antigen interactions into measurable signals, these devices facilitate quick and accurate diagnoses, enhancing patient outcomes. citeturn0search0
Point-of-Care (POC) Diagnostics: The rising popularity of POC diagnostics has made testing more accessible, allowing for immediate results and timely interventions. This shift towards decentralized testing is particularly beneficial in resource-limited settings. citeturn0search1
However, the market faces notable challenges:
Low Diagnosis Rates: Despite the availability of advanced diagnostics, a significant number of individuals with HBV and HCV remain undiagnosed. Factors such as limited awareness, inadequate diagnostic tools, and delivery issues contribute to this gap. citeturn0search3
Cost and Accessibility: The high cost of diagnostics and complex treatment regimens can hinder widespread adoption, particularly in underserved communities. Addressing these economic barriers is crucial for broader market penetration. citeturn0search1
Geographically, North America is expected to account for 47% of the market growth during the forecast period. This dominance is attributed to the increasing incidence of infections and new product launches by established companies in the region. citeturn0search3
In conclusion, the US Hepatitis B and C diagnostics market is on an upward trajectory, propelled by technological innovations and a focus on early detection. While challenges persist, strategic efforts to enhance awareness, reduce costs, and improve accessibility are essential to fully realize the market's potential.
Get an In-Depth Research Analysis of the US Hepatitis B and C Diagnostics Market Size And Forecast [2025-2032]
Roche Diagnostics
Abbott
Siemens
Qiagen
Alere
bioMérieux
Cepheid
Chembio Diagnostics
DiaSorin
Enzo Life Sciences
Hologic
MedMira
OraSure Technologies
Quest Diagnostics
Quidel Corp
Randox Laboratories
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US Hepatitis B and C Diagnostics Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US Hepatitis B and C Diagnostics Market
Diagnostic Kits
Reagents
Instruments
Software Solutions
Molecular Diagnostics
Serological Tests
Point-of-Care Testing
Nucleic Acid Testing (NAT)
Hospital Laboratories
Clinical Laboratories
Research Laboratories
Home Care Settings
Private & Public Healthcare Institutions
Chronic Hepatitis B
Acute Hepatitis B
Chronic Hepatitis C
Acute Hepatitis C
Diagnostic Laboratories
Blood Banks
Pharmaceutical Companies
Academic and Research Institutions
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Hepatitis B and C Diagnostics Market Research Analysis
1. Introduction of the US Hepatitis B and C Diagnostics Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US Hepatitis B and C Diagnostics Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US Hepatitis B and C Diagnostics Market, By Type
6. US Hepatitis B and C Diagnostics Market, By Application
7. US Hepatitis B and C Diagnostics Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US Hepatitis B and C Diagnostics Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/